Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can Brain-Computer interfaces boost stroke recovery?

NCT ID NCT07171073

Symptom relief Sponsor: Erika Endzelyte Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study will test whether using smart technologies like brain-computer interfaces and robotic hand therapy can improve recovery in people who recently had a stroke. 200 participants will be split into four groups: three using different high-tech devices and one receiving standard therapy. Over 6-7 weeks, researchers will measure changes in movement, thinking, and quality of life to see which approach works best.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
RecoveriX (brain-computer interface), Gloreha Aria (robotic hand therapy), and E-Link (interactive rehab system)
What this could lead to
If successful, this could show that smart technologies help stroke patients recover motor and cognitive functions faster than standard therapy alone.
What could go wrong
This is an early-stage study with no phase, so results are uncertain. The devices may not provide significant benefits over standard care, and individual responses may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2025

An estimate. Start dates often move.

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Signed informed consent. * Ischemic stroke confirmed by imaging (CT or MRI). * Hemiplegia/hemiparesis with arm motor deficit (muscle strength ≤ 4 points on Lovett scale). * Time since stroke ≤ 1 month. * No severe cognitive impairment (MMSE ≥ 18). * Native Lithuanian speaker. Exclusion Criteria: * Declines participation. * Contraindications for RecoveriX (metallic implants in the head, cochlear implants, cardiac pacemaker). * Previous craniotomy or severe head trauma with loss of consciousness. * Epilepsy or history of seizures. * Severe aphasia or severe comprehension impairment (MMSE \< 18). * Severe comorbidities affecting biosocial functions. * Previous significant arm function deficits unrelated to stroke. * Severe visual or hearing impairments interfering with participation. * Unilateral neglect syndrome (Hemispatial neglect).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ischemic stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

ischemic stroke stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stroke

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Neurorehabilitation Department

    Kaunas, Kauno, 50161, Lithuania

  • Lithuanian University of Health Sciences, Hospital Kaunas Clinics, Kulautuva Rehabilitation Hospital

    Kaunas, Kauno, 53483, Lithuania

More trials for these conditions

Other studies related to the condition(s) this trial covers.